Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in recurrent or metastatic HNSCC
NCT01377298Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jun 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in head and neck squamous cell carcinoma (HNSCC), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
pazopanib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01377298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01377298.